MG217 Psoriasis by is a Otc medication manufactured, distributed, or labeled by Wisconsin Pharmacal Company. Drug facts, warnings, and ingredients follow.
MG217 PSORIASIS PSORIASIS TREATMENT INTENSIVE STRENGTH- coal tar ointment
Wisconsin Pharmacal Company
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
For the relief or these symptoms associated with psoriasis and/or seborrheic dermatitis
Helps prevent recurrence.
For external use only.
avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
Use caution in exposing skin to sunlight after applying this product, as it may increase your tendency to sunburn for up to 24 hours after application.
Do not use on the scalp unless directed by a physician. If may be difficult to remove from the hair.
MG217 PSORIASIS
PSORIASIS TREATMENT INTENSIVE STRENGTH
coal tar ointment |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Wisconsin Pharmacal Company (800873986) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Wisconsin Pharmacal Company | 800873986 | manufacture(68093-7207) |